{"name":"Harbour BioMed US, Inc.","slug":"harbour-biomed-us-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPRnZQam00d3I5SzNoaDNKSk5kUjdaSV9zM3B5RFpSdWMwWkNrN0JEdGdPeHAzZU51TlFCa0xOdXQyckN3cmt1UnpzQ1FlVm5ObDFIV0R1LWVVU0luUEdmaThJV3JHZzhjM1QxSmZOU0FJYU84bFluREtHR1ltWDdaSm1oTFZRVkRJLUNiWFQtcng1cVpVaTQ5RGhrYmgtQ2NJVGgzMA?oc=5","date":"2026-02-24","type":"deal","source":"The Pharma Letter","summary":"Harbour BioMed strikes license deal with Solstice Oncology - The Pharma Letter","headline":"Harbour BioMed strikes license deal with Solstice Oncology","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-23","type":"deal","source":"South China Morning Post","summary":"Wave of Chinese biotech deals builds with US$1.2 billion Harbour BioMed pact - South China Morning Post","headline":"Wave of Chinese biotech deals builds with US$1.2 billion Harbour BioMed pact","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-21","type":"pipeline","source":"South China Morning Post","summary":"Harbour BioMed stake in US drug developer shows Chinese firms’ growing clout - South China Morning Post","headline":"Harbour BioMed stake in US drug developer shows Chinese firms’ growing clout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPcjZ1Snp6Qk5RdTYzN1VDY3g2UnlvUWthSm9TY2V2b1RkTE1YdWZUVExZRmp2T3NqS3ozREVPbXF2ODM3aEJYMkJ1V19zaWNJTWZheldzTDVLRy1FMGdST2R6S3VvcGd5RmJuRWZNemZDUGhFcWtoeXdUVG9lVEhNV3hqRTJDWFMwTGpIb0UwR1YzTjJOTmNzeVF5NUQ4Zm5hVU1YdUhJS3ptb2FuOE9wYVlhS3ZWZw?oc=5","date":"2026-01-19","type":"deal","source":"Contract Pharma","summary":"Harbour BioMed Exercises Agreement to Buy Spruce Biosciences Common Stock - Contract Pharma","headline":"Harbour BioMed Exercises Agreement to Buy Spruce Biosciences Common Stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNRG12S3NpMEktUmxVUjBCdlhJRFljTjNZbUhFVkZWd05OcVVvTFFNTVdUSDNzTW1BMHQ3U3VjejB1bGlSYTAzQ3k4OFZSa1Q3dHBMbDB1LXRQZHh3Tjl1YVB6LV9hakhBM1BudWRKT3NIOUYtY0t2TUJoWFl4ZHgzUkdwb0g4U2xncEtJOEQ5OExrZVNWT051YTF0QTQwU3lFSFczNS1kZDhwZjZZdnUyRHR1YTU0UVBWZHRDbVJxcDRGU3N4SUxNNGs5Yk90V3JGbEhrRzc3dENOeVlDNC1NVEJWS3hOckZZUkYtaXRPX1RwdWRiTmZib21QcVpJYWM?oc=5","date":"2026-01-13","type":"deal","source":"Citeline News & Insights","summary":"Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China - Citeline News & Insights","headline":"Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQS3UtQW81a2gwaEM4UGYwLWV6VHFmMzdsa2V1SmZiVkdFWkwxUWRVR3BVQWZKcHV2MTRFSnZGaFYyR1V5SlBmMWNCcVJjVnVpek1MXy1mbDFPNElVR25KNUdJVklQTF9ONEdtcktvNURGUkhmYzRHWGNVZm5IM2IwZzUtcjJ4SkFwdzBRcDlQNzJqaUtFUF9HVUVCX3pja1px?oc=5","date":"2025-12-22","type":"deal","source":"BioWorld News","summary":"China-made products account for 30% of global deals in 2025 - BioWorld News","headline":"China-made products account for 30% of global deals in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQNVlFajkyeXFQRjNwRGVxMkxTYXBCOG13ZDZuUWxkT244Qk1PVE11TEY1UmE5ak14U0RHMUMzT3JPbURMc2hxaXU2cHMyTDEyMGNqY2pVQ1lacWZiWHVCV2NDMk5PZFlRTmF3MEVpM0tyM2FzQzhncFctSzZjYTdWZVc0X0lKdVVkQjN4YUl6eU1KcVB5OEtPdlg2ZkhhUWh4UDlaa2d1RktVd2xDWF9sNlFnQWRuN0RXR2c?oc=5","date":"2025-12-17","type":"deal","source":"Contract Pharma","summary":"Harbour BioMed, BMS Partner to Advance Next-Gen Multi-Specific Antibodies - Contract Pharma","headline":"Harbour BioMed, BMS Partner to Advance Next-Gen Multi-Specific Antibodies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPOXdsVkJseUpuXzVEY09zeFRTTVdaNXhfbGdIRVJyOVh2UjQ0WDA4OVFCbFJFNmp6WDR2UkJKVXhDdXk0VEhzQmw3NktndEIzRUpMZWFNaG8tQTZTaFYyWURsRG0tWWFXU3MxOGx5LVhvQjRUTDdLaXJkbkNNZHdsYlI3NmJvZVNSSjBxbUgtenpIRkxHblVxUENEeXUxZUZJLWNvOEZzeXJNaTJkRVVN?oc=5","date":"2025-11-24","type":"pipeline","source":"The Pharma Letter","summary":"Harbour BioMed and AstraZeneca broaden next-gen antibody alliance - The Pharma Letter","headline":"Harbour BioMed and AstraZeneca broaden next-gen antibody alliance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5mVExSckVUQmdrTmVMeTRPbzNjOUxpSEV6MW16YmtWMmpqOHh0MDdTTjI2UGtMRHhzV0ZIeU9TTkxOLUd5NG9Udzk5NHViNkNPOUdwSkE0WklQc0I1MlFlSzA0RGJLU3dmV1FpWllfbWJQejVOeUpkV2FmWk82dw?oc=5","date":"2025-11-07","type":"pipeline","source":"Fortune Business Insights","summary":"Bispecific Antibody Market Size, Share | Forecast Report [2034] - Fortune Business Insights","headline":"Bispecific Antibody Market Size, Share | Forecast Report [2034]","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNLTE4Z0JoMnZuUDNwR3NPVEVLS29QdHVHT2dOd2ZSd3RBTnFkRzU1UGN2dDdaRk1Bbm85SVFaWXNHRXJYRDhqUnpNdDM1dXdPTG93OVBRM3BUYUd5Z2J1YkUtMEkxSVlxendIbnlJS09jaUl2RFNNZm9ZOUNZZjBkU3d6ZnJFOGpSWkNOeTdn?oc=5","date":"2025-09-02","type":"pipeline","source":"BioWorld News","summary":"Chinese biopharma financings up in Hong Kong - BioWorld News","headline":"Chinese biopharma financings up in Hong Kong","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQZVhybmRfemM2THp1X1J0T05rMlJBTFpZUGl1LV8wTWVISm15ZEx6cEF6Z2c4eERTZ2YzUjRnRjVJMHkyQU1uZWdYQ1JUV29LdEZ6MU82a2tQQ19Yd1g5emdBOHNfTS13bGQ2SnhudFBPVTZXNnZNYWdfb3hEWUNRbjNMdEplSHNPRzN1U1BjbWppVXRJSWgzb0FGQzFfVElT?oc=5","date":"2025-08-27","type":"pipeline","source":"PR Newswire","summary":"Harbour BioMed Reports 2025 Interim Results - PR Newswire","headline":"Harbour BioMed Reports 2025 Interim Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPLVg2eEJGTzJEVUJ2Y1lhRnc5SXdWM1htajFPVE5LTGxUNk8tQWh2N3RFaGE4X01XY3A3OUdIcVd6aDdxdnJ1MEUtMFh6UGJqaUp6bHNwb29mVDU3X0hoS3VTdHdkazdLajN4WnRhSXFLSW9MNjhWZmRRZUJ3dlRYelJvSkhjX3hOcW1mZGpZa1N2SXJWX2FseTVySzZtdWNMSkcxV3Zybw?oc=5","date":"2025-06-27","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—Vor-RemeGen, Otsuka-Harbour autoimmune deals; Datroway's lung cancer nod - Fierce Pharma","headline":"Fierce Pharma Asia—Vor-RemeGen, Otsuka-Harbour autoimmune deals; Datroway's lung cancer nod","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}